Immunotherapy News and Research

Latest Immunotherapy News and Research

HDAC6 inhibitors increase efficacy of immunotherapy in triple-negative breast cancer

Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.

6 Aug 2020

Study: Inhibition of TLK protein stimulates the innate immune system

Tousled-like kinases (TLKs) are a potential therapeutic target for cancer treatment due to their central role in DNA repair and replication.

5 Aug 2020

Panthera’s oncology clinical trial sites in the UK are open for research activities

Over a thousand oncology clinical trials have been suspended due to Covid putting back research which is vital for patients across the world.

5 Aug 2020

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

The National Cancer Institute has once again rated the Abramson Cancer Center of the University of Pennsylvania as "exceptional," the highest possible rating for an NCI-designated comprehensive cancer center.

4 Aug 2020

ALKBH5 enzyme shows promising target for cancer immunotherapy

Cancer immunotherapy -; a treatment that better enables a patient's own immune system to attack tumors -; has shown great potential against some cancers. Yet immunotherapy doesn't work against all tumor types, and many patients who initially respond later develop resistance and relapse.

4 Aug 2020

New biomarkers may identify Type 1 diabetes patients who could benefit from immunotherapy

Scientists at UCL have discovered new biomarkers, which may identify those people with Type 1 diabetes who would benefit from the immunotherapy drug Abatacept, a finding which could eventually help thousands manage the disease more effectively.

3 Aug 2020

A blood test may be an easy way to predict who will benefit from immunotherapy

A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, a treatment option for advanced cancers.

3 Aug 2020

New method to detect rare circulating tumor cells in blood samples

Metastasis - the development of tumor growth at a secondary site - is responsible for the majority of cancer-related deaths. It occurs when the primary tumor site sheds cancerous cells which are then circulated through the body via blood vessels or lymph nodes.

3 Aug 2020

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

The Faculty of Medicine has awarded 58 clinical research chairs to top clinician-scientists in a five-year, $40 million investment to drive clinical research excellence and enhance health and patient care.

30 Jul 2020

Immunosuppressive steroids help tumors to evade the immune system

A new study has revealed that tumors can evade the immune system by telling immune cells to produce immunosuppressive steroids.

30 Jul 2020

Study identifies potential drug targets for developing new cancer immunotherapies

A study has revealed that tumours can evade the immune system by telling immune cells to produce immunosuppressive steroids.

30 Jul 2020

Women receiving treatment for cancers are not at increased of being hospitalized for COVID-19

Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows.

30 Jul 2020

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

Black and Hispanic pregnant women in Philadelphia are five times as likely as white and Asian women to have been exposed to the novel coronavirus, according to a new study led by Scott Hensley, PhD, an associate professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, and Karen Marie Puopolo, MD, PhD, an associate professor of Pediatrics and neonatologist at the Children's Hospital of Philadelphia. The study was published today in Science Immunology.

29 Jul 2020

Stand Up To Cancer announces $1.1 million in funding to foster collaborative research

Stand Up To Cancer announced today five new awards that will cut across institutional and national lines to foster collaborative research and explore new paths to improve cancer treatment.

29 Jul 2020

Combining two immunotherapies into a single treatment found to be more effective

Some of the most promising advances in cancer treatment have centered on immunotherapies that rev up a patient's immune system to attack cancer. But immunotherapies don't work in all patients, and researchers have been searching for ways to increase their effectiveness.

23 Jul 2020

Hollings Cancer Center researcher receives NCI grants for cancer immunotherapy studies

Hollings Cancer Center researcher Jessica Thaxton, Ph.D., is the recipient of two grants totaling $3.4 million from the National Cancer Institute for her work in cancer immunotherapy and cell stress, one of which is part of the Cancer Moonshot Initiative on immunometabolism.

23 Jul 2020

Research could lead to more efficient cellular immunotherapies for advanced cancers

Adoptive cell transfer immunotherapy is one of the most promising new treatments for people with hard-to-treat cancers.

23 Jul 2020

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease.

23 Jul 2020

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Experts at City of Hope and the Translational Genomics Research Institute are using one of the world's most comprehensive genomic analysis tools to map out personalized treatment plans for metastatic kidney cancer patients.

22 Jul 2020

Monash University researchers pave way for affordable immunotherapies

Researchers from Monash University’s Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world’s newest forms of immunotherapy: CAR-T cell therapy.

22 Jul 2020

Immunotherapy News and Research

Latest Immunotherapy News and Research

HDAC6 inhibitors increase efficacy of immunotherapy in triple-negative breast cancer

Study: Inhibition of TLK protein stimulates the innate immune system

Panthera’s oncology clinical trial sites in the UK are open for research activities

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

ALKBH5 enzyme shows promising target for cancer immunotherapy

New biomarkers may identify Type 1 diabetes patients who could benefit from immunotherapy

A blood test may be an easy way to predict who will benefit from immunotherapy

New method to detect rare circulating tumor cells in blood samples

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

Immunosuppressive steroids help tumors to evade the immune system

Study identifies potential drug targets for developing new cancer immunotherapies

Women receiving treatment for cancers are not at increased of being hospitalized for COVID-19

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

Stand Up To Cancer announces $1.1 million in funding to foster collaborative research

Combining two immunotherapies into a single treatment found to be more effective

Hollings Cancer Center researcher receives NCI grants for cancer immunotherapy studies

Research could lead to more efficient cellular immunotherapies for advanced cancers

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Monash University researchers pave way for affordable immunotherapies

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in